A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

NCT05279300 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Advanced Lymphoma

Interventions

DRUG: CS5001
BIOLOGICAL: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Lenalidomide
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone

Sponsor

CStone Pharmaceuticals